Trial Profile
Multi-center, Randomized, Active-Controlled, Double-Blind, Non-Inferiority, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia (MARS Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2017
Price :
$35
*
At a glance
- Drugs Mosapride (Primary)
- Indications Dyspepsia
- Focus Therapeutic Use
- Acronyms Mars
- Sponsors Korea United Pharm Inc
- 26 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017